21/06/2024 Healthcare
Meropenem Sulbactam Injection, marketed as Flaxsat-S Injection, combines meropenem, a potent antibiotic, with sulbactam, a β-lactamase inhibitor. This dual action effectively treats severe infections caused by multidrug-resistant bacteria, including those resistant to other antibiotics. By inhibiting bacterial cell wall synthesis and protecting meropenem from degradation, this injection is crucial in combating complex infections like intra-abdominal infections and pneumonia. Careful administration and monitoring ensure optimal therapeutic outcomes while managing potential side effects.Available in PCD Franchise for injectable range and third party manufacturing.
Meropenem Sulbactam Injection, marketed as Flaxsat-S Injection, combines meropenem, a potent antibiotic, with sulbactam, a β-lactamase inhibitor. This...
Cefoperazone Sulbactam Injection, marketed under the brand name Triazon-SB, combines an antibiotic with a beta-lactamase inhibitor to treat severe inf...
Cefromin-SB 1.5 GM combines Cefoperazone and Sulbactam, offering potent antibacterial activity against severe infections. Cefoperazone, a third-genera...
Ciflozone-SB Injection combines Cefoperazone with Sulbactam, offering potent antibacterial action against severe infections. Cefoperazone, a third-gen...
More Details